|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online February 9, 2007
doi: 10.1242/10.1242/dev.02782


1 State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of
Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084,
China.
2 Institut de Génétique et de Biologie Moléculaire et
Cellulaire, CNRS/INSERM/ULP, 1, rue Laurent Fries, BP10142, 67404 Illkirch
Cedex, France.
3 Institute of Molecular and Cell Biology, Proteos, 138673, Singapore.
Authors for correspondence (e-mail:
thisse{at}titus.u-strasbg.fr;
mengam{at}mail.tsinghua.edu.cn)
Accepted 14 December 2006
| SUMMARY |
|---|
|
|
|---|
Key words: Zebrafish, Epiboly, Convergent extension, c-Src, Angiomotin-like2
| INTRODUCTION |
|---|
|
|
|---|
In an effort to screen for factors regulated by Fgf signaling in the
zebrafish embryo, we identified using the cDNA microarray technology Amotl2,
which belongs to the Motin protein family
(Bratt et al., 2002
). Amot, the
founding member of the Motin family, is characterized as a binding partner of
angiostatin, which is an angiogenesis inhibitor
(Troyanovsky et al., 2001
). In
vitro experiments indicate that Amot promotes migration and tube formation of
endothelial cells (Troyanovsky et al.,
2001
). Interestingly, AMOT is involved in invasion of
tumor cells by promoting angiogenesis
(Levchenko et al., 2004
), and
higher levels of AMOT transcripts are detected in human breast tumor
tissues (Jiang et al., 2006
).
The expression of Amot is restricted to angiogenic vessels of lobular
mammary carcinoma developed in Her-2/neu transgenic mice,
and thus Amot can serve as a target for anti-angiogenic therapy
(Holmgren et al., 2006
). Mouse
Amot is expressed in visceral endoderm around gastrulation.
Amot knockout mice die soon after gastrulation due to improper
migration of visceral endoderm (Shimono
and Behringer, 2003
). Apart from controlling cell motility, Amot
may also play a role in regulating the assembly and maintenance of cell-cell
junctions (Bratt et al., 2005
;
Wells et al., 2006
). Amotl1
and Amotl2, the other two members of the Motin family, have been previously
identified in mammals (Bratt et al.,
2002
); however, their biological functions in embryonic
development have not been reported.
In this study, we demonstrate that amotl2 is expressed maternally and in a restricted manner as soon as the zygotic genome begins to be expressed. Inhibition of amotl2 expression by antisense morpholinos causes epiboly arrest and aberrant convergent extension in zebrafish embryos, which coincides with disruption of juxtamembrane actin fibers and formation of membrane protrusion. In vitro analyses reveal that Amotl2 regulates cell migration by binding to and promoting peripheral membrane translocation of the nonreceptor tyrosine kinase c-Src. Taken together, our findings suggest that amotl2 is essential for cell movement in vertebrate embryos, which might be associated with c-Src translocation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Gene identification and construct generation
To identify Fgf-responsive genes, embryos were injected with 10 pg
fgf17b mRNA or 100 pg XFD mRNA encoding a dominant-negative
form of Xenopus Fgf receptor at the one-cell stage. RNAs were
isolated from wild-type and injected embryos at the shield stage,
respectively, and were labeled and hybridized to a zebrafish cDNA microarray
as described before (Lo et al.,
2003
). The sample from wild-type embryos was used as a reference
sample against which samples from injected embryos were compared. In two
repeats, the cDNA #076-A05-2 showed an increase of expression level in
fgf17b-injected samples with a logarithm ratio of 5.0 or 5.9,
respectively. However, this cDNA showed a decrease of expression level in
XFD-injected samples in two repeats, with a logarithm ratio of -3.3
or -2.35, respectively. Thus, this cDNA represented a gene positively
regulated by Fgf signal.
Sequence analysis revealed that the cDNA clone #076-A05-2 contains 5'
partial sequence of putative amotl2 cDNA. The other sequences of
putative amotl2 were cloned by RACE RT-PCR and ligated together. The
amotl2 cDNA sequence was deposited in GenBank with an accession
number DQ887096. The full coding sequence of amotl2 was amplified
with a pair of primers (5'-GGAATTCCATATGAGAACGGCAGAGGAATC-'3 and
5'-GTCCTCGAGTGGACATTGTTATCTCAGATG-3') and subcloned into
pCMV5-Myc, pCMV5-HA or pEGFP-N3 to generate mammalian expression constructs,
or into pXT7 to generate a vector for synthesizing mRNA in vitro. For
generating amotl2
PDZ constructs, another lower primer
(5'-CGGGATCCTTAACTACTTTGCTCACCTTTGGC-3') was used. For in vitro
synthesizing amotl2m mRNA that could not be targeted by
amotl2MO1, a modified upper primer
(5'-GGGGTACCACCATGCGTACCGCTGAAGAGAGCTCAGGAACGGAGCTGCACCG-3')
(substitutes underlined) was used for amplification of the amotl2
coding sequence. To generate zebrafish amotl2
EILI that lack C-terminal
4 aa PDZ-binding domain, a specific upper primer
(5'-GGAATTCCATATGAGAACGGCAGAGGAATC-3') and a lower primer
(5'-CTAGTCTAGATCACACCATGTCATTTTCGACGG-3') were used for PCR
amplification. The coding sequence of human AMOTL2 was amplified from cDNAs
derived from HeLa cells with an upper primer
(5'-CGGAATTCATGAGGACACTGGAAGACTC-3') and a lower primer
(5'-CGGATATCGTCGACTCAGATCAGTATCTCCACC-3'), which were designed
based on human amotl2 sequence in GenBank (NM_016201). The lower primer for
creating human AMOTL2
PDZ that lacks C-terminal 131 residues has a
sequence of 5'-CGGATATCGTCGACTCAGGAGCGCTGCTGAAGG-3'. The coding
sequences of zebrafish c-src (csk - Zebrafish Information
Network), fyn and yes (yes1 - Zebrafish Information
Network) were individually subcloned into the expression vector pCMV5 using
primers 5'-CCGGAATTCCATATGGGTGGAGTCAAGAGTAA-3' and
5'-CGCGGATCCCTAGAGGTTTTCTCCGGGTTG-3' for c-src,
5'-CCGGAATTCCATATGGGCTGTGTGCAATGTAA-3' and
5'-CGCGGATCCTTAGAGGTTGTCCCCGGGTTG-3' for fyn, and
5'-CCGGAATTCCATATGGGCTGTGTCAAGAGTAA-3' and
5'-CGCGGATCCCTACAGGTTGTCTCCGGGCTG-3' for yes.
RNA synthesis, morpholinos, microinjection, whole-mount in situ hybridization
Capped RNAs were synthesized using T7 or SP6 Cap Scribe (Roche) according
to the manufacturer's instructions. Digoxigenin-UTP-labeled antisense RNA
probes were generated by in vitro transcription and used for whole-mount in
situ hybridization. Two antisense morpholinos, amotl2MO1
(5'-CTGATGATTCCTCTGCCGTTCTCAT-3', positioning from 236-260 of
amotl2 sequence (DQ887096)) and amotl2MO2
(5'-CATTTCAGTCTATGTTTAACAGACA-3', positioning from 214-238 of
amotl2 sequence (DQ887096)), were synthesized by Gene Tools, LLC. A
control morpholino (cMO1) has a sequence
(5'-TACTCTTGCCGTCTCCTTAGTAGTC-3') that is inverted from amotl2MO1.
Amotl2MO1 and cMO1 were also synthesized with a 3' carboxyfluorescein
and a 3' lissamine end modification, respectively. Unless otherwise
stated, mRNAs and morpholinos were injected into yolk of fertilized eggs, and
the dose was an estimate for the amount received by each embryo.
Microinjection was performed as before
(Zhao et al., 2003
).
Cell culture, immunostaining and immunoprecipitation
Mammalian cells were grown in DMEM (GIBCO) supplemented with 10% fetal calf
serum (Hyclone). When stimulation was required, the cells were starved for 24
hours and then treated with 100 nmol/l bradykinin (Sigma-Aldrich).
Immunostaining, immunoblotting and co-immunoprecipitation were performed as
before (Xiong et al., 2006
;
Zhang et al., 2004
). For
wound-healing assay, HEK293T or COS1 cells grown on glass slides were
scratched with a sterile pipette tip, followed by transfection with
corresponding plasmid DNAs. Rabbit polyclonal anti-c-Src, rabbit polyclonal
anti-p-c-Src, rabbit polyclonal anti-RhoB and mouse monoclonal anti-EEA1 were
purchased from Santa Cruz Biotechnology. TRITC-conjugated phalloidin was
product of Molecular Probes. The secondary antibodies were products of Jackson
ImmunoResearch Laboratories, Inc. Whole-mount in situ hybridizations were
performed as described before (Thisse et
al., 2004
).
| RESULTS |
|---|
|
|
|---|
We investigated the spatiotemporal expression pattern of amotl2 in zebrafish embryos by whole-mount in situ hybridization. amotl2 transcripts were detected before the 1k-cell stage (Fig. 2A,B), suggesting that it is maternally supplied. At the sphere stage stronger staining was detected in the dorsal blastomeres (Fig. 2C); then amotl2 transcripts were found in the whole gastrula, except in the evacuation zone, which corresponds to the ventral-animal territory of the embryo (Fig. 2D,E). During segmentation, amotl2 is expressed in many distinct domains, including the polster, telencephalon, trigeminal placodes, rhombomeres, trunk neurons, somites and axial vasculature (Fig. 2F-J). The same expression pattern remains during the pharyngula period (Fig. 2K-O), except that amotl2 is also expressed in lateral line primordia and in intersegmental vessels.
To confirm responsiveness of amotl2 expression to Fgf signals, we injected embryos with fgf8 mRNA and examined amotl2 expression. Embryos injected at the one-cell stage expressed amotl2 throughout the animal hemisphere at the shield stage (Fig. 2Q). When a single cell at the animal pole of an embryo at the 32- or 64-cell stage was injected with fgf8 mRNA, amotl2 expression was locally, strongly induced at the shield stage (Fig. 2R,S), indicating that ectopic Fgf signal is able to induce zygotic expression of amotl2. We also treated embryos with various doses of the Fgfr inhibitor SU5402, and examined amotl2 expression at the 60% epiboly stage. As shown in Fig. 2T-W, progressive increase of SU5402 concentration caused amotl2 expression to be progressively restricted to the most dorsal side of the gastrula embryo, showing that endogenous Fgf signaling is required for zygotic expression of amotl2 in ventral and lateral marginal cells.
Knockdown of amotl2 expression inhibits cell migration during embryogenesis
To study functions of endogenous amotl2 in development of
zebrafish embryos, we used two antisense morpholino oligonucleotides,
amotl2MO1 and amotl2MO2, which target different sequences of amotl2,
to block translation of amotl2 mRNA. Both morpholinos effectively
inhibited production of the Amotl2-GFP fusion protein in zebrafish embryos,
while the control morpholino cMO1 had no effect
(Fig. 3). Because amotl2MO1 is
more effective than amotl2MO2, we used amotl2MO1 only in most of our
experiments. Compared to wild-type or cMO1-injected embryos, embryos injected
with amotl2MO1 showed slower epiboly in a dose-dependent manner
(Fig. 4A). When wild-type or
cMO1-injected embryos developed to the bud stage [10 hours post-fertilization
(hpf)], for instance, embryos injected with 1, 2, 3, 4 or 5 ng of amotl2MO1
developed to approximately 100, 95, 75, 70 or 55% epiboly stages,
respectively. Close examinations at higher magnifications revealed that
movements of enveloping layer, deep cells, forerunner cells and yolk syncytial
layer were slower in amotl2MO1-injected embryos (data not shown). At the five-
to six-somite stage (
12 hpf), wild-type embryos have a long
anteroposterior embryonic axis around the yolk due to convergent extension
(CE) movements. At this stage, by contrast, embryos injected with 1-3 ng
amotl2MO1 had a shorter embryonic axis, albeit the epiboly was complete,
suggesting impaired extension movement; and embryos injected with 4 or 5 ng
amotl2MO1 died without completion of epiboly. Injection with 30 ng amotl2MO2
similarly delayed epiboly and impaired extension, implying that targeting
effect of both morpholinos should be specific.
|
|
900 pg amotl2 mRNA and found no
obvious morphological changes (data not shown). Then we tested whether
amotl2 overexpression could rescue amotl2MO1-induced defects in cell
movement. Because the amotl2MO1 sequence is complementary to the first 25
nucleotides of the amotl2 coding sequence, we made base substitutions
in that region so that the resulting amotl2m mRNA could
not be bound by amotl2MO1 while the residue identities were not changed.
Embryos injected with 600 pg amotl2m mRNA alone did not
show any defects (Fig. 4B,C).
When injected with 3 ng amotl2MO1 alone, 16.1% (n=93) of embryos
never completed epiboly and 75.3% of embryos showed epiboly and/or CE defects
at the bud and seven-somite stages (Fig.
4C). When amotl2MO1 and amotl2m mRNA were
co-injected, 50% of embryos (n=96) exhibited slightly slower epiboly
at the bud stage and less severe CE defects at later stages, while the other
embryos looked normal (Fig.
4C). Thus, amotl2 overexpression can compromise the
effect of knockdown of amotl2 expression, further suggesting that
amotl2 is essential for normal epiboly and CE movements of zebrafish
embryos.
We injected a fluorescein-labeled amotl2MO1 (green) or a lissamine-labeled
cMO1 (red) into a single blastomere at the 64-cell stage, and subsequently
analyzed the migration behavior of the derived clone. The injected embryos
were sorted out at the shield stage, based on locations of the labeled progeny
cells, into three groups: dorsal, lateral and ventral, and further observed
during early segmentation (five- to ten-somite stages) and at 24 hpf
(Fig. 5A). When control cMO1
was injected, labeled cells migrated according to their positions on the fate
map for more than 70% of embryos at 24 hpf: dorsal clones colonizing the head,
lateral clones colonizing posterior head and trunk, and ventral clones
populating the tail region. When amotl2MO1 was injected, labeled cells failed
to migrate and clustered on the yolk in more than 80% of embryos at 24 hpf.
Analysis of cell death, using the vital dye Nile Blue Sulfate
(Dupe et al., 1999
), revealed
that clustering of amotl2MO1-injected cells on the yolk at 24 hpf was not
correlated with cell death (data not shown), excluding the possibility that
the morpholino has a lethal effect. It is likely that Amotl2-deficient cells
lose migratory ability and are pushed out to the yolk surface. In addition,
our data suggest that amotl2-mediated migration is a cell-autonomous
effect.
Knockdown of amotl2 expression disrupts membrane protrusion and actin filaments
To look into the effects of knockdown of amotl2 expression on
membrane protrusions, we co-injected the morpholino together with an mRNA
coding for a membrane-targeted GFP into one blastomere at the 64-cell stage
and observed by confocal fluorescent microscopy at the end of gastrulation
(Fig. 5B). Cells injected with
the membrane GFP mRNA alone or in combination with 4 ng cMO1 had ruffles on
the surface, including filopodia, while cells co-injected with the membrane
GFP mRNA and 4 ng amotl2MO1 were rounded, with few filopodia. The number of
protrusions per cell was 7.4±0.5 for membrane GFP injection (average
for 30 cells of five embryos), 8.2±0.8 for cMO1 injection (average for
38 cells of five embryos), and 0.65±0.3 for amotl2MO1 injection
(average for 47 cells of nine embryos). These results indicate that
amotl2 is required for formation of membrane protrusion. Given that
microfilaments play important roles in cell migration, we examined by
phalloidin staining the distribution of actin filaments in embryonic cells
following amotl2 expression knockdown. As shown in
Fig. 5C, juxtamembrane actin
fibers were less abundant and discontinuous in the epiblast cells of
amotl2MO1-injected embryos at the shield stage, compared with those in
cMO1-injected embryos. These data suggest that amotl2 is required for
formation and ordered array of actin filaments during early embryogenesis.
|
PDZ, which lacks sequence encoding the
C-terminal 117 residues that includes the putative PDZ-binding domain. We
injected amotl2
PDZ mRNA, side by side with
full-length amotl2 mRNA, into single-cell embryos and observed
morphological changes during gastrulation and early segmentation. When the
tailbud formed in wild-type or amotl2 mRNA-injected embryos, the yolk
plug in amotl2
PDZ-injected embryos (69/79) had not
been completely covered by the blastoderm
(Fig. 6A), suggesting that
overexpression of amotl2
PDZ leads to a slower epiboly
process. During the early segmentation period, the distance between the
rostral and caudal ends of the embryonic axis on the ventral side was longer
in amotl2
PDZ-injected embryos than in wild-type
embryos, being indicative of an extension defect. We then examined expression
of hgg1, dlx3 and ntl in injected embryos. As shown in
Fig. 6B, overexpression of
amotl2
PDZ resulted in wider neural plate (marked by
dlx3), wider but shorter notochord (marked by ntl), and
slower migration of the anterior prechordal plate (marked by hgg1) in
66.1% (n=56) of amotl2
PDZ-injected embryos,
suggesting defective CE movements. Taken together, the effects of
amotl2
PDZ overexpression on embryonic cell movements
resemble those of amotl2MO1 injection, suggesting that Amotl2
PDZ has a
dominant-negative effect on endogenous Amotl2 activity. To confirm Amotl2
function in cell movements is absolutely mediated by its C-terminal
PDZ-binding domain (EILI motif), we made an amotl2
EILI mutant that
lacks only four residues (EILI) at the C-terminus. Injection of 400 pg
amotl2
EILI mRNA caused defects in convergent
extension in 52.5% (n=40) of embryos
(Fig. 6B), which confirms the
requirement of the EILI motif for normal function of Amotl2. In another
experiment, co-injection of 400 pg amotl2
EILI mRNA
with equal amount of wild-type amotl2 mRNA led to only 30%
(n=60) of embryos with convergent extension defects, compared with
49.1% (n=57) of embryos with the same phenotypes that were injected
with 400 pg amotl2
EILI mRNA alone. This result
suggests that Amotl2
EILI interferes with the function of wild-type
Amotl2.
We further tested the effects of Amotl2
PDZ on cell migration in
mammalian cells by wound-healing assay. HEK293T and COS1 cells were
transfected with pEGFP-N3, pAmotl2-EGFP or pAmotl2
PDZ-EGFP and
scratches were made. Twenty-four hours after wounding, the number of
GFP-positive cells in the wound areas was counted. We found that transfection
with pAmotl2-EGFP promoted migration of cells into the wound area, whereas
transfection with pAmotl2
PDZ-EGFP inhibited such migration
(Fig. 6C). However, neither
Amotl2-EGFP nor Amotl2
PDZ-EGFP influenced cell proliferation in NIH3T3
cells (data not shown). These results further confirm that the mutant form
Amotl2
PDZ plays an inhibitory role in cell migration.
To investigate the effects of Amotl2
PDZ overexpression on
distribution of actin filaments, Myc-Amotl2
PDZ, which was derived from
zebrafish Amotl2, or HA-AMOTL2
PDZ, which was derived from human AMOTL2,
was transfected into HeLa cells and F-actin was stained with phalloidin. As
shown in Fig. 6D,
overexpression of either mutant Amotl2 resulted in less abundance and
disruption of peripheral F-actin. This result is consistent with the
observation in zebrafish embryos injected with amotl2MO1
(Fig. 5C). In addition, most
cells (82%) overexpressing the mutant Amotl2 looked rounded with a cell
length:width ratio of less than 2:1, while only 16% of cells overexpressing
wild-type Amolt2 had a similar shape.
Amotl2 binds to and promotes translocation of c-Src
The non-receptor tyrosine kinase Src plays important roles in actin
cytoskeleton remodeling and cell motility by phosphorylating various
substrates (Frame, 2004
;
Ishizawar and Parsons, 2004
).
As Amotl2 also affects these aspects, we asked if Amotl2 interacted with Src.
To test interaction between fish Amotl2 and exogenous c-Src, HA-Amotl2 was
co-transfected with GFP-tagged wild-type (Src-WT-GFP) or constitutively active
mutant c-Src (Src-Y527F-GFP) (Sandilands
et al., 2004
) into human HEK293T cells. In the precipitates pulled
down with anti-GFP antibody, Amotl2 was detected by anti-HA immunoblotting,
suggesting that Amotl2 can bind to both wild-type and active c-Src with higher
affinity to the active form (Fig.
7A). In a reciprocal experiment with anti-HA immunoprecipitation
and anti-GFP immunoblotting, the Amotl2/c-Src complexes were not detected,
which might result from mask of the GFP epitope by anti-HA antibody in the
complexes. Then, we tested interaction between Amotl2 and endogenous c-Src in
HEK239T cells. In the precipitates pulled down with anti-HA antibody,
endogenous c-Src was detected by anti-Src antibody
(Fig. 7B), indicating that
overexpressed Amotl2 physically binds to endogenous c-Src. Furthermore,
immunostaining showed that HA-Amotl2 co-localized with Src-WT-GFP or
endogenous c-Src in mammalian cells (Fig.
7C). Taken together, these data indicate that Amotl2 can form
complexes with c-Src. Fyn and Yes are also Src family protein tyrosine kinases
(Thomas and Brugge, 1997
), and
have been found to play a role in convergent extension cell movements during
gastrulation of zebrafish embryos (Jopling
and den Hertog, 2005
). We tested whether Amotl2 could also
physically associate with Fyn and Yes. When Myc-Amotl2 was coexpressed with
HA-Fyn or HA-Yes in HEK293T cells, reciprocal co-immunoprecipitation failed to
detect Myc-Amotl2/HA-Fyn or Myc/HA-Yes complexes
(Fig. 7D). This suggests that
Amotl2 is unable to bind Fyn or Yes.
|
PDZ, however, Src-Y527F-GFP reached the cell periphery and
stopped at the base of filopodia. We then examined distribution of endogenous
phosphorylated c-Src in cells transfected with Myc-Amotl2 or
Myc-Amotl2
PDZ using antibody against phospho-c-Src (Thr420). We found
that phospho-c-Src was abundant at the periphery of cells transfected with
Myc-Amotl2 but less abundant at the periphery of cells transfected with
Myc-Amotl2
PDZ (Fig. 7F).
These data suggest that overexpression of the mutant Amotl2 inhibits membrane
translocation of activated c-Src.
|
| DISCUSSION |
|---|
|
|
|---|
In zebrafish embryos, knockdown of amotl2 expression caused
disordered array of juxtamembrane actin fibers and loss of filopodia and
lamellipodia. Several lines of evidence from in vitro experiments support the
hypothesis that Amotl2 promotes cell migration, at least in part, by
facilitating peripheral translocation of phosphorylated c-Src via endosomes.
First, Amotl2 is co-localized with RhoB-positive endosomes that have been
reported to be required for translocation of activated c-Src to focal adhesion
complexes (Sandilands et al.,
2004
). Second, Amotl2 physically associates with c-Src with
stronger affinity for phosphorylated c-Src, and largely co-localizes with
c-Src. Third, overexpression of Amotl2
PDZ blocks membrane targeting of
activated c-Src. c-Src regulates cell motility by interacting with and
modulating numerous cellular factors that modulate cell surface structure,
cell-cell adhesion and actin cytoskeleton
(Frame, 2004
;
Huttelmaier et al., 2005
;
Ishizawar and Parsons, 2004
;
Nelson and Nusse, 2004
). Thus,
Amotl2 may promote cell migration through c-Src in multiple mechanisms.
However, it remains to be elucidated whether c-Src relays Amotl2 function in
cell movements in vivo.
|
In this study, amotl2 has been identified as an Fgf-responsive
gene. Fgf signals have been found to play roles in cell movements during
gastrulation of vertebrate embryos (Ciruna
and Rossant, 2001
; Nutt et
al., 2001
; Yang et al.,
2002
). We tested genetic interaction between Fgf signaling and
amotl2. We found that overexpression of either fgf17b mRNA
or dominant-negative fgfr1 mRNA failed to rescue defective cell
movements caused by loss of function of amotl2 in zebrafish embryos
(data not shown). It is likely that amotl2 directly mediates activity
of Fgf signaling and it also exerts effects through other signaling pathways.
The potential roles of Amotl2 in Fgf signaling and the underlying mechanisms
need to be investigated in the future.
|
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Bratt, A., Wilson, W. J., Troyanovsky, B., Aase, K., Kessler, R., Van Meir, E. G. and Holmgren, L. (2002). Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298,69 -77.[CrossRef][Medline]
Bratt, A., Birot, O., Sinha, I., Veitonmaki, N., Aase, K.,
Ernkvist, M. and Holmgren, L. (2005). Angiomotin regulates
endothelial cell-cell junctions and cell motility. J. Biol.
Chem. 280,34859
-34869.
Bruckner, K., Pablo Labrador, J., Scheiffele, P., Herb, A., Seeburg, P. H. and Klein, R. (1999). EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 22,511 -524.[CrossRef][Medline]
Ciruna, B. and Rossant, J. (2001). FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 1, 37-49.[CrossRef][Medline]
Dupe, V., Ghyselinck, N. B., Thomazy, V., Nagy, L., Davies, P. J., Chambon, P. and Mark, M. (1999). Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208, 30-43.[CrossRef][Medline]
Fincham, V. J., Unlu, M., Brunton, V. G., Pitts, J. D., Wyke, J.
A. and Frame, M. C. (1996). Translocation of Src kinase to
the cell periphery is mediated by the actin cytoskeleton under the control of
the Rho family of small G proteins. J. Cell Biol.
135,1551
-1564.
Frame, M. C. (2004). Newest findings on the
oldest oncogene; how activated src does it. J. Cell
Sci. 117,989
-998.
Funke, L., Dakoji, S. and Bredt, D. S. (2005). Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions. Annu. Rev. Biochem. 74,219 -245.[CrossRef][Medline]
Holmgren, L., Ambrosino, E., Birot, O., Tullus, C., Veitonmaki,
N., Levchenko, T., Carlson, L. M., Musiani, P., Iezzi, M., Curcio, C. et
al. (2006). A DNA vaccine targeting angiomotin inhibits
angiogenesis and suppresses tumor growth. Proc. Natl. Acad. Sci.
USA 103,9208
-9213.
Huttelmaier, S., Zenklusen, D., Lederer, M., Dictenberg, J., Lorenz, M., Meng, X., Bassell, G. J., Condeelis, J. and Singer, R. H. (2005). Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438,512 -515.[CrossRef][Medline]
Ip, Y. T. and Gridley, T. (2002). Cell movements during gastrulation: snail dependent and independent pathways. Curr. Opin. Genet. Dev. 12,423 -429.[CrossRef][Medline]
Ishizawar, R. and Parsons, S. J. (2004). c-Src and cooperating partners in human cancer. Cancer Cell 6, 209-214.[CrossRef][Medline]
Jiang, W. G., Watkins, G., Douglas-Jones, A., Holmgren, L. and Mansel, R. E. (2006). Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer. BMC Cancer 6, 16.[CrossRef][Medline]
Jopling, C. and den Hertog, J. (2005). Fyn/Yes and non-canonical Wnt signalling converge on RhoA in vertebrate gastrulation cell movements. EMBO Rep. 6, 426-431.[CrossRef][Medline]
Kaplan, K. B., Swedlow, J. R., Varmus, H. E. and Morgan, D.
O. (1992). Association of p60c-src with endosomal membranes
in mammalian fibroblasts. J. Cell Biol.
118,321
-333.
Levchenko, T., Aase, K., Troyanovsky, B., Bratt, A. and
Holmgren, L. (2003). Loss of responsiveness to chemotactic
factors by deletion of the C-terminal protein interaction site of angiomotin.
J. Cell Sci. 116,3803
-3810.
Levchenko, T., Bratt, A., Arbiser, J. L. and Holmgren, L. (2004). Angiomotin expression promotes hemangioendothelioma invasion. Oncogene 23,1469 -1473.[CrossRef][Medline]
Lo, J., Lee, S., Xu, M., Liu, F., Ruan, H., Eun, A., He, Y., Ma,
W., Wang, W., Wen, Z. et al. (2003). 15000 unique
zebrafish EST clusters and their future use in microarray for profiling gene
expression patterns during embryogenesis. Genome Res.
13,455
-466.
Marlow, F., Topczewski, J., Sepich, D. and Solnica-Krezel, L. (2002). Zebrafish Rho kinase 2 acts downstream of Wnt11 to mediate cell polarity and effective convergence and extension movements. Curr. Biol. 12,876 -884.[CrossRef][Medline]
Myers, D. C., Sepich, D. S. and Solnica-Krezel, L. (2002). Bmp activity gradient regulates convergent extension during zebrafish gastrulation. Dev. Biol. 243, 81-98.[CrossRef][Medline]
Nelson, W. J. and Nusse, R. (2004). Convergence
of Wnt, beta-catenin, and cadherin pathways. Science
303,1483
-1487.
Nourry, C., Grant, S. G. and Borg, J. P. (2003). PDZ domain proteins: plug and play! Sci. STKE 2003,RE7 .
Nutt, S. L., Dingwell, K. S., Holt, C. E. and Amaya, E.
(2001). Xenopus Sprouty2 inhibits FGF-mediated gastrulation
movements but does not affect mesoderm induction and patterning.
Genes Dev. 15,1152
-1166.
Sandilands, E., Cans, C., Fincham, V. J., Brunton, V. G., Mellor, H., Prendergast, G. C., Norman, J. C., Superti-Furga, G. and Frame, M. C. (2004). RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev. Cell 7,855 -869.[CrossRef][Medline]
Schier, A. F. and Talbot, W. S. (2005). Molecular genetics of axis formation in zebrafish. Annu. Rev. Genet. 39,561 -613.[CrossRef][Medline]
Shimono, A. and Behringer, R. R. (2003). Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Curr. Biol. 13,613 -617.[CrossRef][Medline]
Solnica-Krezel, L. (2005). Conserved patterns of cell movements during vertebrate gastrulation. Curr. Biol. 15,R213 -R228.[CrossRef][Medline]
Thisse, B. and Thisse, C. (2005). Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287,390 -402.[Medline]
Thisse, B., Heyer, V., Lux, A., Alunni, V., Degrave, A., Seiliez, I., Kirchner, J., Parkhill, J. P. and Thisse, C. (2004). Spatial and temporal expression of the zebrafish genome by large-scale in situ hybridization screening. Methods Cell Biol. 77,505 -519.[Medline]
Thomas, S. M. and Brugge, J. S. (1997). Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13,513 -609.[CrossRef][Medline]
Tian, T. and Meng, A. M. (2006). Nodal signals pattern vertebrate embryos. Cell. Mol. Life Sci. 63,672 -685.[CrossRef][Medline]
Timpson, P., Jones, G. E., Frame, M. C. and Brunton, V. G. (2001). Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr. Biol. 11,1836 -1846.[CrossRef][Medline]
Topczewski, J., Sepich, D. S., Myers, D. C., Walker, C., Amores, A., Lele, Z., Hammerschmidt, M., Postlethwait, J. and Solnica-Krezel, L. (2001). The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension. Dev. Cell 1,251 -264.[CrossRef][Medline]
Troyanovsky, B., Levchenko, T., Mansson, G., Matvijenko, O. and
Holmgren, L. (2001). Angiomotin: an angiostatin binding
protein that regulates endothelial cell migration and tube formation.
J. Cell Biol. 152,1247
-1254.
Warga, R. M. and Kimmel, C. B. (1990). Cell
movements during epiboly and gastrulation in zebrafish.
Development 108,569
-580.
Wells, C. D., Fawcett, J. P., Traweger, A., Yamanaka, Y., Goudreault, M., Elder, K., Kulkarni, S., Gish, G., Virag, C., Lim, C. et al. (2006). A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 125,535 -548.[CrossRef][Medline]
Xiong, B., Rui, Y., Zhang, M., Shi, K., Jia, S., Tian, T., Yin, K., Huang, H., Lin, S., Zhao, X. et al. (2006). Tob1 controls dorsal development of zebrafish embryos by antagonizing maternal beta-catenin transcriptional activity. Dev. Cell 11,225 -238.[CrossRef][Medline]
Yang, X., Dormann, D., Munsterberg, A. E. and Weijer, C. J. (2002). Cell movement patterns during gastrulation in the chick are controlled by positive and negative chemotaxis mediated by FGF4 and FGF8. Dev. Cell 3,425 -437.[CrossRef][Medline]
Zhang, L., Zhou, H., Su, Y., Sun, Z., Zhang, H., Zhang, L.,
Zhang, Y., Ning, Y., Chen, Y. G. and Meng, A. (2004).
Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal
receptors. Science 306,114
-117.
Zhao, J., Cao, Y., Zhao, C., Postlethwait, J. and Meng, A. (2003). An SP1-like transcription factor Spr2 acts downstream of Fgf signaling to mediate mesoderm induction. EMBO J. 22,6078 -6088.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
S. Jia, Z. Ren, X. Li, Y. Zheng, and A. Meng smad2 and smad3 Are Required for Mesendoderm Induction by Transforming Growth Factor- /Nodal Signals in Zebrafish J. Biol. Chem., January 25, 2008; 283(4): 2418 - 2426. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||